SCYNEXIS, Inc. - Common Stock (SCYX)
0.8000
+0.0037 (0.46%)
NASDAQ · Last Trade: Oct 3rd, 9:45 AM EDT
Via Benzinga · October 2, 2025
Via Benzinga · September 30, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · September 30, 2025
Via Benzinga · September 30, 2025

Exploring SCYNEXIS INC (NASDAQ:SCYX)'s growth characteristics.
Via Chartmill · May 20, 2024
Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · September 30, 2025
The market is filled with gapping stocks in Tuesday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via Chartmill · September 30, 2025
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via Chartmill · September 30, 2025
Let's delve into the US markets on Friday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Via Chartmill · May 16, 2025

SCYX stock results show that SCYNEXIS missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 9, 2024

Pre-market stock movers are a hot topic that traders are going to want to know about and we have all of the latest news on Tuesday morning!
Via InvestorPlace · July 23, 2024

Discover the growth potential of top small-cap stocks in the consumer finance, healthcare equipment and pharmaceutical industries.
Via InvestorPlace · July 22, 2024

These are three of the best cheap drug developer stocks for investors to keep an eye as their growth could be imminent.
Via InvestorPlace · July 11, 2024

The broader healthcare sector enjoys a powerfully relevant narrative. Undervalued biotech stocks makes the case even more attractive.
Via InvestorPlace · July 1, 2024

Read here about the top under-$10 growth stocks primed for financial success through strategic partnerships and innovative product offerings.
Via InvestorPlace · May 31, 2024

Learn more about the growth stocks under $10 with progressive fundamentals in the healthcare and technology sectors.
Via InvestorPlace · May 23, 2024

SCYX stock results show that SCYNEXIS beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 8, 2024

SCYX stock results show that SCYNEXIS missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 28, 2024

Shares of Resources Connection, Inc. (NASDAQ: RGP) rose sharply in pre-market trading following better-than-expected results for its second quarter.
Via Benzinga · January 4, 2024

Via Benzinga · January 3, 2024

Via Benzinga · January 2, 2024

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher by around 30 points on Monday. The Dow traded down 0.07% to 33,939.93 while the NASDAQ rose 0.24% to 13,243.56. The S&P 500 also rose, gaining, 0.19% to 4,328.30.
Via Benzinga · September 25, 2023

Via Benzinga · September 25, 2023